Active	Status	Sponsor type	Region	Phase	Filter
2 Active 1 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Clemmons, Amber B
FONDO-LOW, NCT06588413: Olanzapine 2.5 vs 5 mg in Quadruplet Nausea/Vomiting Prophylaxis Before High-Dose Melphalan	Recruiting	3	172	US	Olanzapine, Zyprexa	Augusta University	Multiple Myeloma, Autologous Stem Cell Transplantation	10/27	10/27
NCT06142396: Pilot Study Dara-CyBorD in Newly Diagnosed Multiple Myeloma Patients with Renal Failure	Not yet recruiting	1	30	US	Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide, and Dexamethasone, DaraCyBord	Augusta University, Janssen Scientific Affairs, LLC	Multiple Myeloma, Renal Failure	11/25	11/27